AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Sep - Fabtech will meet investors/analysts in Mumbai on 24 Sept 2026 through Kaptify Consulting.
Source: Bse
Fabtech Technologies Limited (FABTECH)
Small CapIT stocks · Small cap · NSE
Fabtech Technologies Limited operates in Pharma Tech, within the IT sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 21 Oct, 04:45 am ISTDetails
Quote21 Oct, 04:45 am IST
Base fundamentals06 Oct 2026 · screener
Latest result24 Jul, 11:41 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · IT P/E 21.4 (n=204)
Technical timing lens
Trend score and candlestick chart
51Neutralfull bear SMA stack · SMA20 -4.7% / mo · MACD − · near 52W low · sector +14.5pp vs Nifty 500 (3M)
Stock trend: 18
Sector RS: 100
Sector 3M: +8.9% vs Nifty 500 -5.6%
IT FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
FABTECHD candles · FIT view-14.8%Latest close ₹131.39 on 2026-10-19
Bar
+1.0%
RSI
33
MACD hist
-1.01
52W pos
2%
2026-10-19O ₹130.10H ₹133.90L ₹128.33C ₹131.39Vol 60,389 sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
FABTECHNifty ITNifty 500
- FABTECH
- -13.2%
- Nifty 500
- -5.6%
- Nifty IT
- +8.1%
- Vs Nifty 500
- -7.6 pp
Chart stats
19 Oct 2026- From 52W high
- -50.0%
- 52W range position
- 2%
- ATR (14)
- 4.3%
- Volume vs 20D
- 0.62x
- Avg traded value
- ₹1.4 Cr
- 20D price channel
- ₹128.3 - ₹150.4
₹262.8
₹128.3 - ₹262.8
₹5.7
Latest completed session
20-session average
30.2% annualized volatility
Research snapshot
What the evidence says now
Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · UNDERVALUED61
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Average35
Revenue +10.3% · PAT NDF YoY
Technical
Neutral51
Price trend and sector-relative-strength timing.
Valuation
Legacy model+69.3%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence68
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Average · 35/100Rev +10% YoY · margin expansion
Filed 24 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹75 Cr | +10.3% | -52.7% |
| EBITDA | ₹4.2 Cr | +168.3% | -80.9% |
| Operating margin | 5.7% | +1478 bps | -836 bps |
| PAT | ₹4.2 Cr | NDF | -80.9% |
| PAT margin | 5.6% | +1462 bps | -831 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 12.90
- P/B
- 1.50
- EV/EBITDA
- 13.92
- Market Cap
- 626.00Cr
Profitability
- ROE
- 12.50%
- ROCE
- 13.60%
- ROA
- 7.49%
- Dividend Y
- 0.42%
Growth (CAGR)
- Revenue 5Y
- 28.00%
- EPS 5Y
- 36.00%
- Revenue 3Y
- 28.00%
- EPS 3Y
- 19.00%
Balance Sheet
- Debt/Equity
- 0.17
- Interest Coverage
- 11.25×
- Altman Z
- 3.50
- Book Value
- 94.40
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 2/5
- OCF
- —
- EPS TTM
- 13.31
Shareholding
- Promoter Hold
- 68.94%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 12%
Financial History
Updated 19/10/2026
Revenue
₹ CrLatest: 75.0-52.7% vs prev
Net Profit
₹ CrLatest: 4.2-80.9% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term trend down. RSI 33. Wait for confirmation.
- Price < SMA20 < SMA50 < SMA200 — full bearish stack.
- SMA20 falling (~5.0% over last month) — short-term momentum negative.
- RSI(14) at 33 — rising, no extreme reading.
- MACD below signal but histogram contracting — bearish momentum easing.
- Within 5% of 52-week low — testing support.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
13
RS percentile
Stage 4 Downtrend
1M return
-11.2%
3M return
-13.2%
6M return
-16.0%
1Y return
-48.6%
RS 1D
-1
RS 20D
-41
Sector rank
#8
Industry rank
#39
Stage evidence
- Price is 12.9% below the 30-week proxy.
- The 50-DMA is below the 30-week proxy and its slope is falling -0.6%.
- Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
improving
Industry
improving
Relative-strength line vs Nifty 500 (base 100)
256 observations
19 Oct 2026Value 75.85+1.88%
RS vs Nifty 50076
Valuation & peers
U-Score 61 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 61 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Deep Value
Fundamental score breakdown
U band · UNDERVALUEDValuation24/30
Growth20/25
Quality0/20
Balance Sheet12/15
Cash Flow1/10
Piotroski
6/9 (+3)
Penalties
1
Raw sum
61
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
61/100 · legacy band UNDERVALUED
Positive drivers
- Fair-value margin of safety is positive at 69.3%.
- Valuation contributes 24/30 to the score.
- Growth contributes 20/25 to the score.
Main drags
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Cash flow is weaker at 1/10; verify the latest quarterly trend.
- Valuation is weaker at 24/30; verify the latest quarterly trend.
Sector valuation model
Healthcare valuation: PE/EVEBITDA with regulatory and pipeline checks
Healthcare valuation needs both earnings quality and regulatory/pipeline context.
Primary lens
PE and EV/EBITDA adjusted for product mix and R&D/pipeline quality.
Secondary checks
USFDA risk, launch pipeline, margin trend, domestic vs export mix.
Main risk check
Regulatory setbacks or one-off product cycles can distort valuation.
PE
12.9
PB
1.5
EV/EBITDA
13.9
ROE
12.5%
ROCE
13.6%
FCF Yield
—
Debt/Equity
0.2
MoS
+69.3%
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
61
Previous: 61
Legacy U-Score band
UNDERVALUED
Previous: UNDERVALUED
Margin of safety
+69.3%
Previous: +69.3%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
61
61
61
61
60
60
61
63
63
63
61
61
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹168.14
+21.9% MoS
Growth-justified P/E
32.1
Growth-justified Value
₹427.25
+69.3% MoS
PEG
0.44
Comparable companies
Peers
Business-comparable peers in IT — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
IKS
Small
Inventurus Knowledge Solutions Limited
IT Services / Digital
match 122
58
38.9
31.4%
-18%
FAIR VALUE
VIRINCHI
Small
Virinchi Limited
IT Services / Digital
match 120
10
—
-4.7%
—
OVERVALUED
HVAX
SME
HVAX Technologies Ltd.
IT Services / Digital
match 119
57
14.7
18.0%
+56%
FAIR VALUE
HGM
Small
HandsOn Global Management (HGM) Limited
IT Services / Digital
match 118
8
—
-13.8%
—
OVERVALUED
AAKAAR
SME
Aakaar Medical Technologies Ltd.
IT Services / Digital
match 117
55
15.2
17.1%
+55%
FAIR VALUE
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Fabtech Technologies Limited operates in Pharma Tech, within the IT sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
68Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 56th percentile of the scored universe and 50th percentile within IT. Main check: results consistency is weak at 50/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
28 docs text-extracted · 5 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
56th percentile
overall median 67 · IT: 50th pctile, median 69 · Small: 60th pctile, median 66
Evidence depth
Financial-only
28 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
55
watch · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
58
watch · capital discipline
Results
50
watch · quarterly consistency
Trust positives
- ▸Promoter holding is 68.9%.
- ▸Promoter pledge is zero.
- ▸3/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸ROCE trend is -7.7%.
- ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
- ▸OPM spread across recent quarters is 43.6%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Fabtech Technologies Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 17 Sep - Fabtech won a INR 21 crore turnkey project in a CIS country for a medical-device facility.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 11 Sep - FTS Cleanrooms Systems completes 14,000 sqm Himalaya Wellness facility in UAE under a year.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Change in Directorate 24 Aug - AGM approved Amjad Adam Arbani’s reappointment and Naushad Panjwani’s five-year independent director term.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 19 Aug - Wholly owned subsidiary won AED 9.92 million turnkey flavour manufacturing project in UAE, completed in six months.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 1 Aug
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Jul
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Change in Directorate 25 Jun - Board approved Rs 24 crore ODI in Fabtech Technologies LLC, Rs 2.49 crore in FT Institutions, and higher borrowing limits.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 15 Jun - Fabtech secured Botswana Vaccine Institute contract worth about Rs 31.23 crore, to execute within 14 months.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 15 Jun - Fabtech secured a ₹31.23 crore veterinary vaccine facility contract in Botswana.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 May - Fabtech Technologies Limited has informed about Copy of Newspaper Publication for the dispatch of Postal Ballot Notice.
Source: Bse
Announcement
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 29 May - Postal ballot seeks approval for two independent directors; e-voting runs June 1-30, 2026.
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.